DTIL — Precision BioSciences Share News
0.000.00%
Last trade - 00:00- $288.44m
- $229.02m
- $34.26m
Precision BioSciences Q3 net loss narrows on non-cash warrant gains
Precision BioSciences Inc reports results for the quarter ended June 30 - Earnings Summary
Precision BioSciences Q2 net loss widens on warrant liability charge
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Precision Biosciences - Enters First Amendment To Loan And Security Agreement With Banc Of California - SEC Filing
Precision Bio Q1 sales beat, helped by milestone revenue
U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems
U.S. STOCKS ON THE MOVE-Nike, PNC Financial, Papa John's
U.S. STOCKS ON THE MOVE-Gitlab, Snap, Robinhood
U.S. STOCKS ON THE MOVE-Broadcom, BofA, Snap
Precision BioSciences up as hepatitis B gene‑editing trial expands in Europe
Precision Bio rises after quarterly results beat estimates
Precision BioSciences Q4 revenue beats analyst estimates on Novartis deal
Brief: Precision BioSciences, Inc. Q4 Net Income USD 20.133 Million
U.S. STOCKS ON THE MOVE-Agricultural stocks, Papa John's, Oil companies
U.S. STOCKS ON THE MOVE-Nebius, Scienture, Clearmind
U.S. STOCKS ON THE MOVE-Oracle, Nike, Unifirst
Precision Bio rises as U.S. patents bolster experimental hepatitis B therapy